Phase
Condition
Tinnitus
Deafness
Hearing Loss
Treatment
Prednisone tablet
Ginkgo Biloba Extract
Clinical Study ID
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
18-65 years old;
a primary complaint of frequent occurrences of subjective tinnitus lasting at least 5 minutes within the past 3 months ;
a definition of normal hearing in line with the World Report on Hearing (2021), ofwhich the average value of hearing threshold at 500, 1000, 2000, 4000 Hz in betterear was less than 20 decibels;
a score of more than 16 points on the Tinnitus Handicap Inventory (THI), whichindicates that the level of tinnitus exceeds mild severity;
a state of good general condition.
Exclusion
Exclusion Criteria:
had previous history of middle ear pathology, apparent history of noise exposure,noise trauma or head injury;
had received treatment for their current condition before the study;
taken oral steroids within 3 months before randomization;
had hearing implants;
had participated in other clinical trials and have not terminated the trials;
had a history of known corticosteroid contraindications (including osteoporosis,peptic ulcers, poorly controlled hypertension, diabetes, chronic liver or renalinsufficiency, tumorous condition, alcohol abuse, pregnancy, or takingestrogen-containing oral contraceptive steroids);
auditory hallucinations or other conditions deemed inappropriate for inclusion bythe investigator.
Study Design
Study Description
Connect with a study center
Eye and ENT Hospital of Fudan University
Shanghai,
ChinaSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.